2018 Global Biosimilars and Biologics Industry Report - History, Present and Future

November 2018 | 143 pages | ID: 20609014A23PEN
Prof Research

Abstracts

The global market size of Biosimilars and Biologics is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:

• North America
• South America
• Asia & Pacific
• Europe
• MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Biosimilars and Biologics as well as some small players. The information for each competitor includes:

• Company Profile
• Main Business Information
• SWOT Analysis
• Sales, Revenue, Price and Gross Margin
• Market Share

We also can offer customized report to fulfill special requirements of our clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Biosimilars and Biologics Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Biosimilars and Biologics by Region
8.2 Import of Biosimilars and Biologics by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT BIOSIMILARS AND BIOLOGICS MARKET IN NORTH AMERICA (2013-2018)

9.1 Biosimilars and Biologics Supply
9.2 Biosimilars and Biologics Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT BIOSIMILARS AND BIOLOGICS MARKET IN SOUTH AMERICA (2013-2018)

10.1 Biosimilars and Biologics Supply
10.2 Biosimilars and Biologics Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT BIOSIMILARS AND BIOLOGICS MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Biosimilars and Biologics Supply
11.2 Biosimilars and Biologics Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT BIOSIMILARS AND BIOLOGICS MARKET IN EUROPE (2013-2018)

12.1 Biosimilars and Biologics Supply
12.2 Biosimilars and Biologics Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT BIOSIMILARS AND BIOLOGICS MARKET IN MEA (2013-2018)

13.1 Biosimilars and Biologics Supply
13.2 Biosimilars and Biologics Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL BIOSIMILARS AND BIOLOGICS MARKET (2013-2018)

14.1 Biosimilars and Biologics Supply
14.2 Biosimilars and Biologics Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL BIOSIMILARS AND BIOLOGICS MARKET FORECAST (2019-2023)

15.1 Biosimilars and Biologics Supply Forecast
15.2 Biosimilars and Biologics Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Biosimilars and Biologics Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Biosimilars and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Biosimilars and Biologics Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Biosimilars and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Biosimilars and Biologics Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Biosimilars and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Biosimilars and Biologics Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Biosimilars and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Biosimilars and Biologics Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Biosimilars and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Biosimilars and Biologics Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Biosimilars and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Biosimilars and Biologics Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Biosimilars and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Biosimilars and Biologics Report
Table Primary Sources of Biosimilars and Biologics Report
Table Secondary Sources of Biosimilars and Biologics Report
Table Major Assumptions of Biosimilars and Biologics Report
Figure Biosimilars and Biologics Picture
Table Biosimilars and Biologics Classification
Table Biosimilars and Biologics Applications List
Table Drivers of Biosimilars and Biologics Market
Table Restraints of Biosimilars and Biologics Market
Table Opportunities of Biosimilars and Biologics Market
Table Threats of Biosimilars and Biologics Market
Table Key Raw Material of Biosimilars and Biologics and Its Suppliers
Table Key Technologies of Biosimilars and Biologics
Table Cost Structure of Biosimilars and Biologics
Table Market Channel of Biosimilars and Biologics
Table Biosimilars and Biologics Application and Key End Users List
Table Latest News of Biosimilars and Biologics Industry
Table Recently Merger and Acquisition List of Biosimilars and Biologics Industry
Table Recently Planned/Future Project List of Biosimilars and Biologics Industry
Table Policy Dynamics Update of Biosimilars and Biologics Industry
Table 2013-2023 Export of Biosimilars and Biologics by Region
Table 2013-2023 Import of Biosimilars and Biologics by Region
Table 2013-2023 Balance of Trade of Biosimilars and Biologics
Figure 2013 2018 and 2023 Global Trade Map of Biosimilars and Biologics
Table 2013-2018 North America Supply of Biosimilars and Biologics
Figure 2013-2018 North America Biosimilars and Biologics Supply and GAGR
Table 2013-2018 North America Biosimilars and Biologics Downstream Demand List
Figure 2013-2018 North America Biosimilars and Biologics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Biosimilars and Biologics Demand by Type
Figure 2013-2018 North America Biosimilars and Biologics Price
Table 2013-2018 Key Countries Supply of Biosimilars and Biologics in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Biosimilars and Biologics in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Biosimilars and Biologics
Figure 2013-2018 South America Biosimilars and Biologics Supply and GAGR
Table 2013-2018 South America Biosimilars and Biologics Downstream Demand List
Figure 2013-2018 South America Biosimilars and Biologics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Biosimilars and Biologics Demand by Type
Figure 2013-2018 South America Biosimilars and Biologics Price
Table 2013-2018 Key Countries Supply of Biosimilars and Biologics in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Biosimilars and Biologics in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Biosimilars and Biologics
Figure 2013-2018 Asia & Pacific Biosimilars and Biologics Supply and GAGR
Table 2013-2018 Asia & Pacific Biosimilars and Biologics Downstream Demand List
Figure 2013-2018 Asia & Pacific Biosimilars and Biologics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Biosimilars and Biologics Demand by Type
Figure 2013-2018 Asia & Pacific Biosimilars and Biologics Price
Table 2013-2018 Key Countries Supply of Biosimilars and Biologics in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Biosimilars and Biologics in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Biosimilars and Biologics
Figure 2013-2018 Europe Biosimilars and Biologics Supply and GAGR
Table 2013-2018 Europe Biosimilars and Biologics Downstream Demand List
Figure 2013-2018 Europe Biosimilars and Biologics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Biosimilars and Biologics Demand by Type
Figure 2013-2018 Europe Biosimilars and Biologics Price
Table 2013-2018 Key Countries Supply of Biosimilars and Biologics in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Biosimilars and Biologics in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Biosimilars and Biologics
Figure 2013-2018 MEA Biosimilars and Biologics Supply and GAGR
Table 2013-2018 MEA Biosimilars and Biologics Downstream Demand List
Figure 2013-2018 MEA Biosimilars and Biologics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Biosimilars and Biologics Demand by Type
Figure 2013-2018 MEA Biosimilars and Biologics Price
Table 2013-2018 Key Countries Supply of Biosimilars and Biologics in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Biosimilars and Biologics in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Biosimilars and Biologics by Region
Figure 2013-2018 Global Supply and CAGR of Biosimilars and Biologics by Region
Table 2013-2018 Global Biosimilars and Biologics Downstream Demand List by Region
Figure 2013-2018 Global Biosimilars and Biologics Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Biosimilars and Biologics Type-wise Demand by Region
Figure 2013-2018 Global Biosimilars and Biologics Price
Table Main Business and Biosimilars and Biologics Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Biosimilars and Biologics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Biosimilars and Biologics Sales Revenue and Growth Rate
Figure 2013-2018 Company A Biosimilars and Biologics Market Share
Table Main Business and Biosimilars and Biologics Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Biosimilars and Biologics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Biosimilars and Biologics Sales Revenue and Growth Rate
Figure 2013-2018 Company B Biosimilars and Biologics Market Share
Table Main Business and Biosimilars and Biologics Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Biosimilars and Biologics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Biosimilars and Biologics Sales Revenue and Growth Rate
Figure 2013-2018 Company C Biosimilars and Biologics Market Share
Table Main Business and Biosimilars and Biologics Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Biosimilars and Biologics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Biosimilars and Biologics Sales Revenue and Growth Rate
Figure 2013-2018 Company D Biosimilars and Biologics Market Share
Table Main Business and Biosimilars and Biologics Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Biosimilars and Biologics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Biosimilars and Biologics Sales Revenue and Growth Rate
Figure 2013-2018 Company E Biosimilars and Biologics Market Share
Table Main Business and Biosimilars and Biologics Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Biosimilars and Biologics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Biosimilars and Biologics Sales Revenue and Growth Rate
Figure 2013-2018 Company F Biosimilars and Biologics Market Share
Table Main Business and Biosimilars and Biologics Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Biosimilars and Biologics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Biosimilars and Biologics Sales Revenue and Growth Rate
Figure 2013-2018 Company G Biosimilars and Biologics Market Share